AKT1 and neoplasm: As expected, these reductions were also observed following lenvatinib treatment (Figure 4a,b), which inhibited AKT activation.[23] We next performed TUNEL analyses and showed that both the Insig1/2 loop 1 peptide and lenvatinib treatment induced cell apoptosis in tumor tissues (Figure 4c,d).